Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: Results of a prospective phase-II trial

European Journal of Surgical Oncology

Volumn 30, Issue 9, 2004, Pages 963-971

  Brucher B L D M ^a   Stein, H J ^a   Zimmermann, F ^b   Werner, M ^b   Sarbia, M ^b   Busch, R ^b   Dittler, H J ^a   Molls, M ^b   Fink, U ^a   Siewert, J R ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Esophageal carcinoma; Multimodal treatment; Neoadjuvant therapy; Radiochemotherapy

Indexed keywords

FLUOROURACIL; SCOPOLAMINE BUTYL BROMIDE;

ABDOMINAL PAIN; ADVANCED CANCER; ANEMIA; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL TRIAL; CONSTIPATION; CONTINUOUS INFUSION; DIARRHEA; DRUG FATALITY; ESOPHAGUS CARCINOMA; FOLLOW UP; HAND FOOT SYNDROME; HERPES; HISTOPATHOLOGY; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NAUSEA; NEUTROPENIA; PERIODONTITIS; PHASE 2 CLINICAL TRIAL; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION BEAM; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; URINARY TRACT INFECTION; VOMITING;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 7744234343     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2004.06.008     Document Type: Article

References (55)

1. N. Ando T. Iizuka T. Kakegawa et al. A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: The Japan Clinical Oncology Group Study [see comments] J Thorac Cardiovasc Surg 114 2 1997 205-209
2. J.O. Group A comparison of chemotherapy and radiotherapy as adjuvant treatment to surgery for esophageal carcinoma. Japanese Esophageal Oncology Group Chest 104 1 1993 203-207
3. P. Teniere J.M. Hay A. Fingerhut P.L. Fagniez Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research Surg Gynecol Obstet 173 2 1991 123-130
4. U. Fink H.J. Stein H. Bochtler et al. Neoadjuvant therapy for squamous cell esophageal carcinoma Ann Oncol 5 Suppl. 3 1994 17-26
5. J.L. Raoul E. Le Prise B. Meunier et al. Neoadjuvant chemotherapy and hyperfractionated radiotherapy with concurrent low-dose chemotherapy for squamous cell esophageal carcinoma Int J Radiat Oncol Biol Phys 42 1 1998 29-34
6. M. Wang X.Z. Gu W.B. Yin et al. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: Report on 206 patients Int J Radiat Oncol Biol Phys 16 2 1989 325-327
7. K. Nygaard S. Hagen H.S. Hansen et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer World J Surg 16 6 1992 1104-1109
8. B. Launois D. Delarue J.P. Campion M. Kerbaol Preoperative radiotherapy for carcinoma of the esophagus Surg Gynecol Obstet 153 5 1981 690-692
9. M. Gignoux A. Roussel B. Paillot et al. The value of preoperative radiotherapy in esophageal cancer: Results of a study by the EORTC Recent Results Cancer Res 110 1988 1-13
10. S.J. Arnott W. Duncan G.R. Kerr et al. Low dose preoperative radiotherapy for carcinoma of the oesophagus: Results of a randomized clinical trial Radiother Oncol 24 2 1992 108-113
11. S.J. Arnott W. Duncan M. Gignoux et al. Preoperative radiotherapy in esophageal carcinoma: A meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group) Int J Radiat Oncol Biol Phys 41 3 1998 579-583
12. P. Schlag Randomized study of preoperative chemotherapy in squamous cell cancer of the esophagus. CAO Esophageal Cancer Study Group Chirurg 63 9 1992 709-714
13. J.A. Roth H.I. Pass M.M. Flanagan et al. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus J Thorac Cardiovasc Surg 96 2 1988 242-248
14. S. Law M. Fok S. Chow et al. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: A prospective randomized trial [see comments] J Thorac Cardiovasc Surg 114 2 1997 210-217
15. D.P. Kelsen R. Ginsberg T.F. Pajak et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer N Engl J Med 339 27 1998 1979-1984
16. E. Le Prise P.L. Etienne B. Meunier et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus Cancer 73 7 1994 1779-1784
17. J.F. Bosset M. Gignoux J.P. Triboulet et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus N Engl J Med 337 3 1997 161-167
18. Medical Research Council Oesophageal Cancer Working Group Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomised controlled trial Lancet 359 9319 2002 1727-1733
19. T.C. Kok Jv. Lanschot P.D. Siersema et al. Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: Final report of a phase III multicenter randomized controlled trial Proc ASCO 16 1997 177a
20. Group. MRCMUGTC Medical Research Council (MRC) randomised phase III trial of surgery with or without pre-operative chemotherapy in resectable cancer of the esophagus Br J Surg 83 Suppl. 1 2000 1
21. C. Apinop P. Puttisak N. Preecha A prospective study of combined therapy in esophageal cancer Hepatogastroenterology 41 4 1994 391-393
22. H. Bartels H.J. Stein J.R. Siewert Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer Br J Surg 85 6 1998 840-844
23. U. Fumagalli Panel of Experts. Resective surgery for cancer of the thoracic esophagus. Results of a consensus conference Dis Esoph 9 1996 13-19
24. H.J. Stein A. Sendler U. Fink J.R. Siewert Multidisciplinary approach to esophageal and gastric cancer Surg Clin North Am 80 2 2000 659-682
25. J.A. Ajani B. Ryan T.A. Rich et al. Prolonged chemotherapy for localised squamous carcinoma of the oesophagus Eur J Cancer 1992 880-884
26. U. Fink H.J. Stein H. Wilke et al. Multimodal treatment for squamous cell esophageal cancer World J Surg 19 2 1995 198-204
27. U. Fink H.J. Stein J.R. Siewert Multimodal therapy of tumors of the upper gastrointestinal tract Chirurg 69 4 1998 349-359
28. J.R. Siewert B.L.D.M. Brücher H.J. Stein U. Fink Esophagus carcinoma-systemic or local risk of recurrence-which perioperative measures are successful? Langenbecks Arch Chir Suppl Kongressbd 115 1998 290-294
29. A.B. Miller B. Hoogstraten M. Staquet A. Winkler Reporting results of cancer treatment Cancer 47 1 1981 207-214
30. http://ctep.info.nih.gov/CTC3/ctc.htm Actual Common toxicity criteria. Internet 2002.
31. H. Akiyama Surgery for carcinoma of the esophagus Curr Probl Surg 17 2 1980 53-120
32. J.R. Siewert A.H. Hölscher J.D. Roder H. Bartels En-bloc esophagectomy in esophageal cancer Langenbecks Arch Chir 373 1998 367-376
33. H.J. Stein H. Bartels J.R. Siewert Esophageal carcinoma: 2-stage operation for preventing mediastinitis in high risk patients Chirurg 72 8 2001 881-886
34. L.H. Sobin Ce. Wittekind TNM classification of malignant tumors 5th ed. 1997 Wiley/Liss New York
35. A.M. Mandard F. Dalibard J.C. Mandard et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations Cancer 73 11 1994 2680-2686
36. E.L. Kaplan P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 75 1958 457-487
37. R. Peto M.C. Pike P. Armitage et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples Br J Cancer 35 1 1977 1-39
38. H.J. Dittler U. Fink G.R. Siewert Response to chemotherapy in esophageal cancer Endoscopy 26 9 1994 769-771
39. M.L. Hordijk T.C. Kok J.H. Wilson A.H. Mulder Assessment of response of esophageal carcinoma to induction chemotherapy Endoscopy 25 9 1993 592-596
40. G. Isenberg A. Chak M.I. Canto et al. Endoscopic ultrasound in restaging of esophageal cancer after neoadjuvant chemoradiation Gastrointest Endosc 48 2 1998 158-163
41. E. Laterza G. de Manzoni A. Guglielmi et al. Endoscopic ultrasonography in the staging of esophageal carcinoma after preoperative radiotherapy and chemotherapy Ann Thorac Surg 67 5 1999 1466-1469
42. S. Mallery J. Van Dam Interventional endoscopic ultrasonography: Current status and future direction J Clin Gastroenterol 29 4 1999 297-305
43. L.D. Roubein R. DuBrow C. David et al. Endoscopic ultrasonography in the quantitative assessment of response to chemotherapy in patients with adenocarcinoma of the esophagus and esophagogastric junction Endoscopy 25 9 1993 587-591
44. H.J. Dittler Surgical endoscopy for staging and the selection of procedure Chirurg 73 1 2002 2-8
45. A. Meining H.J. Dittler A. Wolf et al. You get what you expect? A critical appraisal of imaging methodology in endosonographic cancer staging Gut 50 5 2002 599-603
46. J.F. Botet C.J. Lightdale A.G. Zauber et al. Preoperative staging of esophageal cancer: Comparison of endoscopic US and dynamic CT Radiology 181 2 1991 419-425
47. G. Zuccaro Jr. T.W. Rice J. Goldblum et al. Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer Am J Gastroenterol 94 4 1999 906-912
48. D.R. Jones L.A. Parker Jr. F.C. Detterbeck T.M. Egan Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy Cancer 85 5 1999 1026-1032
49. H.A. Wieder B.L.D.M. Brücher F. Zimmermann et al. Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment J Clin Oncol 22 5 2004 900-908
50. B.L.D.M. Brücher W. Weber M. Bauer et al. Neoadjuvant therapy in esophageal squamous cell carcinoma: Response evaluation by positron emission tomography Ann 2001 Surg
51. N.I. Khushalani C.G. Leichman G. Proulx et al. Oxaliplatin in combination with protracted-infusion Fluorouracil and radiation: Report of a clinical trial for patients with esophageal cancer J Clin Oncol 20 12 2002 2844-2850
52. J.R. Siewert H.J. Stein M. Feith et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer: Lessons from more than 1,000 consecutive resections at a single center in the western World Ann Surg 234 3 2001 360-369
53. B.P. Whooley S. Law S.C. Murthy et al. Analysis of reduced death and complication rates after esophageal resection Ann Surg 233 3 2001 338-344
54. B.L.D.M. Brücher K. Specht H. Stein et al. Cyclin D1 as a predictive marker in patients with esophageal squamous cell carcinoma and neoadjuvant radiochemotherapy Proc Am Soc Clin Oncol 22 2003 289
55. N. Zantl H.J. Stein B.L.D.M. Brücher et al. Ischemic spinal cord syndrome after transthoracic esophagectomy: Two cases of a rare neurologic complication Dis Esophagus 13 4 2000 328-332